Combination Therapy for Choroidal Neovascularization from Toxoplasmosis
Author Information
Author(s): Rishi Pukhraj Venkataraman, Anusha Rishi
Primary Institution: Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya
Hypothesis
Can combination photodynamic therapy and bevacizumab effectively treat choroidal neovascularization associated with toxoplasmosis?
Conclusion
Combination therapy with photodynamic therapy and intravitreal bevacizumab is effective in treating choroidal neovascularization secondary to toxoplasma retinochoroiditis.
Supporting Evidence
- The patient's visual acuity improved from 20/120 to 20/30 after treatment.
- Choroidal neovascularization regressed at 8 weeks of follow-up.
Takeaway
A 14-year-old girl with vision problems due to an eye infection was treated with two types of medicine, and her vision got much better after a few weeks.
Methodology
The patient underwent verteporfin photodynamic therapy followed by an intravitreal injection of bevacizumab after 2 days.
Limitations
Only one case was reported, limiting the generalizability of the findings.
Participant Demographics
A 14-year-old girl.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website